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INTRODUCTION
Numerous studies of structure-activity relationships (SARs) in the cannabinoid
series have been published; e.g., see review by Sofia (1978) and some more recent
work by Martin et al. (1984a, 1984b) and Narimatsu et al. (1985). An
observation which emerges from a review of all of these studies is that some
cannabinoids can be structurally dissimilar as in delta-9-tetrahydrocannabinol
(delta-9-THC) and Abbott 40656 (Rosell et al. 1979) and yet can have similar
activities; whereas others, which show only slight structural differences as in 10-
alpha-OH-delta-8-THC and 10-beta-OH-delta-8-THC (Edery et al. 1971). can
exhibit dramatic activity differences (figure 1). This observation emphasizes that
a common basis for the activity of these compounds must be sought in more than
their mere three-dimensional structures.
Traditionally, cannabinoid SARs have been focused almost entirely on the
independent contribution of certain structural groups ("functional groups") of the
molecules. These SARs have been compiled into extensive "lists of requirements"
(Razdan 1984). Certain regions or conformations of the molecules have been
proposed to be important. These regions or conformations include a methyl
group in the plane of the aromatic ring, a free phenol, and a free C-4(C-5’)
aromatic position (Edery et al. 1971); the phenolic hydroxyl group (Uliss et al.
1975); the side chain (Osgood et al. 1978); nonplanarity (Binder et al. 1979); and
planarity of the molecule (Burstein et al. 1983). Stereoselectivity in the activity
of the tetrahydrocannabinols has been reported (Dewey et al. 1984). This type of
approach in SAR studies often assumes the following: that functional groups
must react directly with specific sites in the receptor, that modification of one
group does not affect the reactivity of another, and that geometric and
stereometric factors, such as distance and spatial relationships between functional
groups, are all important. Such focus on isolated aspects of the cannabinoids
ignores the fact that the molecular properties that are directly responsible for the
molecular interactions (that lead to the pharmacological effect) are encoded in the
entire molecular structure. To date, no characterization of the entire molecule
and correlation of this characterization with activity has been attempted in the
cannabinoid field.
The importance of quantum chemical methods in describing the physical and
chemical properties of molecules is evident in every facet of modern chemical
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FIGURE 1. Cannabinoids (a) which are structurally dissimilar yet exhibit similar
activities, and (b) which are structurally similar yet exhibit different activities.
From Reggio and Mazurek 1987. Copyright 1986 by Elsevier Science Publishers
B.V. (Amsterdam).
research and is very well documented. In the study of biological systems,
experimental data must be obtained in a variety of forms and from many
different sources. The value of quantum chemical approaches to the study of
biological systems is in an ability to analyze, interpret, and rationalize all
experimental observations on molecular processes in a unified language based on
the primary principles of physics. Considerable evidence exists proving the
relative success of theoretical approaches. These approaches have elucidated
specific mechanisms of drug action, have provided a basis for rational drug
design, and have led to conclusions about the nature of drug-receptor
interactions (Dearden 1983; Vida and Gordon 1984). We have used theoretical
approaches to successfully describe the molecular determinants for binding of
methylenedioxytryptamines at SHT/LSD receptors (Reggio et al. 1981) and have
also used theoretical approaches to explain the role that tautormerism plays in the
activation of the histamine-H2 receptor by 2-methyl and 4-methylhistamine
(Reggio and Mazurek 1987). The basic assumption in any of these theoretical
studies of drug action is that the interaction between drugs and their biological
targets is dependent on the same molecular parameters that determine chemical
interactions and reactions. Molecular Reactivity Characteristics (MRCs) such as
molecular electrostatic potentials (MEP), polarizabilities, and proton affinities are
molecular properties that determine specific chemical reactivity. In theoretical
studies of structure-activity relationships, such MRCs are used to establish how
the information necessary for receptor recognition and activation is encoded in
the molecular structure of the drug.
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Despite the extensive application of theoretical methods in the study of many
pharmacological systems, very little attention has been focused on the
cannabinoids to date. Those theoretical studies on cannabinoids which have been
published have not focused on the calculation of molecular reactivity
characteristics. Most of these studies have concentrated on the calculation of
conformation in an attempt to predict the most probable geometry (lowest energy
conformer) and its relation to activity. The structures and energies of delta-9-
THC and three other cannabinoids obtained by Westheimer calculations and
extended Huckel molecular orbital calculations have been reported (Archer et al.
1970). Theoretical studies of cannabinoids with analgetic and anticonvulsant
activity have also been reported (Johnson et al. 1982; Tamir et al. 1980). The
work presented here extends beyond the considerations which have prevailed in
theoretical studies of the cannabinoids. The aim of this work is to reveal
elements of molecular reactivity that are related to psychopharmacological
activity.
A major step in identifying the MRCs necessary for cannabinoid activity was to
select a template molecule (a molecule with demonstrated activity whose MRCs
can be used as a basis for comparison with those of other cannabinoids). Since
(-)trans-delta-9-THC (delta-9-THC) has been reported to be the major
psychoactive component of cannabis (Gaoni and Mechoulam 1964, 1971) and
since studies indicate that it can exert behavioral effects without metabolic
activation (Carney et al. 1979), delta-9-THC was chosen as the template molecule
for this study. Figure 2 illustrates the numbering systems which are commonly
employed in the literature for delta-9-THC.
FIGURE 2. An illustration of the two numbering systems which are commonly
employed for the cannabinoids. From Reggio and Mazurek 1987. Copyright 1986
by Elsevier Science Publishers B.V. (Amsterdam).
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Our first working hypothesis deals with two components of the delta-9-THC
structure which confer reactivating characteristics upon the molecule that are
crucial to activity. These components are the lone pairs of electrons of the
phenol oxygen (these lone pairs generate reactivity properties dependent on the
orientation of the OH bond relative to the carbocyclic ring, Ring A), and the
orientation of the carbocyclic ring, Ring A (this ring and its orientation generate
hydrophobic properties). The spatial arrangements of these reactivity
characteristics are the components of the template to which the characteristics of
other cannabinoids can subsequently be compared.
Template for Cannabinoid Activity
Recently, we reported the characterization of the template molecule delta-9-THC
(Reggio and Mazurek, 1987). Since the molecular reactivity characteristics of
delta-9-THC are to be used as a basis of comparison with other cannabinoids,
the essential features of the template are presented here. The reader should refer
to the original paper (Reggio and Mazurek 1987), however, for all calculational
details.
The lowest energy conformer of delta-9-THC as obtained by conformational
analysis is shown in figure 3. It is clear from this figure that delta-9-THC is a
nonplanar molecule. The carbocyclic ring (Ring A) of delta-9-THC exists in a
half-chair conformation. Ring B assumes a conformation such that the axial C6
methyl group is on the same side of the molecule as H
H10a than is the other methyl group. In this optimized
10a and is much closer to
structure, the phenolic
hydrogen points away from the carbocyclic ring (dihedral angle, C2-C1-0-H = -
lo). Figure 4 shows a different perspective of the molecule. Here, delta-9-THC
is shown in the direction parallel to the vector from C2 to C10b.From this
perspective, the conformation of the carbocyclic ring (Ring A) causes the top
part of the ring to move to the left, thus permitting no protrusion of Ring A into
the bottom face of the molecule. It is part of our working hypothesis that this
orientation is necessary for cannabinoid activity. The conformation of the
carbocyclic ring may allow for nondirectional hydrophobic interactions.
The lone pairs of electrons of the phenol oxygen generate directional reactivity
properties dependent on the orientation of the OH bond relative to the
carbocyclic ring. Studies of molecular energy as a function of rotation about the
C1-O axis reveal that two minimum energy conformations of the phenolic OH
exist. In Conformation I, the phenolic OH is slightly bent out of the plane of
the aromatic ring with the hydrogen pointing away from Ring A (C2-C1-O-H
dihedral angle,  = -1°). In Conformation II, the phenolic hydrogen is below the
plane of the aromatic ring and is pointing toward Ring A ( = 155°). The
conformation of the rest of the molecule remains essentially unchanged.
The molecular electrostatic potential (MEP) is a molecular reactivity characteristic
that determines specific chemical reactivity. It is an important determinant of
drug action. The electrostatic potential field extends into space and influences
nearby molecules. Unless the fields of a drug and its receptor are complemen-
tary, they will not attract or bind to one another. Indeed, electrostatic forces
appear to guide an incoming drug into its receptor site and align so that shorter
range binding forces can take effect (Tucker 1984). Therefore, a very direct
indication of the nature and extent of electrostatic drug-receptor interactions can
be obtained by mapping the potential generated by a molecule.
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FIGURE 3. Conformation of delta-9-THC (with propyl side chain) as
determined by MM2. From Reggio and Mazurek 1987. Copyright 1986 by
Elsevier Science Publishers B.V. (Amsterdam).
FIGURE 4. Conformation of delta-9-THC as determined by MM2: here the
perspective of Ring A is viewed in the direction parallel to the vector from C2 to
C10b . From Reggio and Mazurek 1987. Copyright 1986 by Elsevier Science
Publishers B.V. (Amsterdam).
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The calculated electrostatic potential patterns generated by the bottom face of
delta-9-THC in each of its minimum energy conformers are shown in figures 5
and 6. These patterns are composed of lines of equipotential energy in kcal/mole
that would be felt by a test positive charge placed at any specified point on the
map. Figures 5 and 6 illustrate the regions of negative potential in planes
parallel to the benzene ring at distances of 1.5 Ås below the plane of the ring.
Because delta-9-THC is a nonplanar molecule. the MEPs differ depending upon
whether the molecule is viewed from above or below. We found that the change
in the position of the phenol group from Conformation I to Conformation II
caused a distinguishable difference in the MEPs of the two conformers when
viewed from the bottom face.
At this stage of the investigation, it was impossible to identify which conforma-
tion of the phenolic OH of delta-9-THC (I or II) was more relevant at the site of
action. Hence, the MEPs shown in figures 5 and 6 along with the conformation
of Ring A, as illustrated in figure 4, formed the preliminary set of molecular
reactivity characteristics for cannabinoid activity.
Refinement of the Template
In order to refine our template, a comparison of the MRCs of delta-9-THC with
those of another cannabinoid was undertaken. Edery et al. (1971) reported that
in rhesus monkey behavioral tests the replacement of the phenolic hydrogen of
delta-9-THC with a methyl group renders the molecule inactive. This inactive
cannabinoid, O-methyl-delta-9-THC (figure 7), was selected for comparison in
order to assess the importance of the position of the lone pairs of electrons of the
phenol oxygen. We report here the results of our comparison of the properties of
O-methyl-delta-9-THC with those of the delta-9-THC reactivity template.
METHODS OF PROCEDURE
Conformational Study of O-Methyl-Delta-9-THC
The first step in the characterization was the conformational analysis of O-
methyl-delta-9-THC. The force field or molecular mechanics method as encoded
in the program MM2 (Allinger and Yuh 1980) was used in this analysis. The
force field available in MM2 has been parameterized for oxygen containing
molecules and has proven satisfactory for the calculation of structures and
energies of oxygen containing compounds (Allinger et al. 1980). The X-ray
structure of delta-9-THC Acid B (Rosenquist and Ottersen 1975) was used to
obtain an input geometry (i.e., bond lengths, bond angles, and dihedral angles for
the fused ring skeleton of delta-9-THC). Necessary atoms were added to this
skeleton at standard bond lengths and bond angles (Mitchell and Cross 1965) to
produce an input geometry for O-methyl-delta-9-THC in the MM2 calculation.
In the calculational scheme for the template molecule, delta-9-THC, molecular
size constraints necessitated reducing the pentyl side chain to propyl (Reggio and
Mazurek 1987). In order to maintain consistency, the side chain in O-methyl-
delta-9-THC was also reduced to propyl. Such a modification was acceptable
since the focus of this study is on the fused ring structure and the phenol group
and not on the side chain.
Because the position of the methoxy group was very important to our working
hypothesis, two studies of the molecular energy as a function of rotation about
the C1-O axis were conducted. In the first study, the dihedral driver option in
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FIGURE 5. Molecular electrostatic potential of the bottom face of delta-9-THC
(Conformational I). Contours represent the MEP in a plane 1.5Å below the
aromatic ring. Values are in Kcal/mole. From Reggio and Mazurek 1987.
Copyright 1986 by Elsevier Science Publishers B.V. (Amsterdam).
FIGURE 6. Molecular electrostatic potential of the bottom face of delta-9-THC
(Conformational II). See figure 5 for details. From Reggio and Mazurek 1987.
Copyright 1986 by Elsevier Science Publishers B.V. (Amsterdam).
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FIGURE 7. O-methyl-delta-9-THC
the MM2 program (Allinger and Yuh 1980) was used. Rotations in 36 steps were
made about the C1-O axis.
In the second study, an SCF calculation was performed for a model fragment of
O-methyl-delta-9-THC (see figure 8). The Gaussian 80 system of programs and
the STO-3G basis set were employed here (Fluder et al. 1980). Initially, all
atoms in the fragment were frozen in their optimized positions. These positions
were determined by MM2 calculations for the full molecule. Rotations of the
methoxy group in 18 steps were made about the C1-O axis.
RESULTS AND DISCUSSION
Conformational Analysis
Figure 9 shows the minimum energy conformer of O-methyl-delta-9-THC as
obtained from the MM2 calculation. Previous studies have predicted that the
cyclohexene ring (Ring A) of delta-9-THC should exist predominantly in a half-
chair-like conformation (Archer et al. 1970). The present calculations indicate
that Rng A retains this conformation in O-methyl-delta-9-THC. As a result of
the interaction between the C6 methyl groups and H6a , Ring B assumes a con-
formation such that the axial C6 methyl group is on the same side of the
molecule as H10a and iS much
substituents on C6 and C6a
closer to H10a than is the other methyl group. The
are staggered with respect to one another (optimized
C10a -C6a -C6 -O5 dihedral angle is 63°). Here, the numbering system employed is
the same as that for delta-9-THC (see figure 2).
The C1 methoxy group is subject to steric interaction with the C10 proton. This
interaction causes the methoxy oxygen to bend slightly out of the plane of the
benzene ring. The methoxy group optimizes at a position away from Ring A
(optimized C2-C1-O-C dihedral angle is -5°).
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FIGURE 8. Model fragment for O-methyl-delta-9-THC.
FIGURE 9. Conformation of O-methyl-delta-9-THC (with propyl side chain) as
determined by MM2.
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Optimized bond lengths are within .01 Å of the following values: Csp P2-Csp2
1.40 Å, Csp 2-Csp3 1.51 Å, Csp 3-Csp 3 1.54 Å, Csp2-O 1.37 Å, Csp3-O
1.41 Å, Csp2-H 1.10 Å, and Csp3-H 1.11 Å.
Figure 10 shows a perspective of the molecule viewed in the direction parallel to
the vector from C2 to C10b From this perspective, the conformation of Ring A
causes the top part of the ring to move to the left, thus permitting no protrusion
of Ring A into the bottom face of the molecule. A comparison of figure 10 with
figure 4 reveals that the position of Ring A in O-methyl-delta-9-THC mimics
that of Ring A in delta-9-THC.
The results of the MM2 study of molecular energy as a function of rotation
about the C1-O axis are summarized in figure 11. There are local minima at  =
-500 and 85° separated by a 0.8 kcal barrier. The SCF results for the model
fragment of O-methyl-delta-9-THC agreed very well with those above. The
SCF method pinpointed two minimum energy conformers  = -5° and  = 85°
separated by a 1.0 kcal barrier.
It is clear from figure 11 that a  of 155° (which corresponds to Conformation II
of delta-9-THC) does not represent an energy minimum for the molecule. In
fact, in the MM2 study, the conformation with  = 155° is 7.3 kcal higher in
energy than the minimum energy conformer of O-methyl-delta-9-THC.
In its minimum energy conformation, the methoxy group of O-methyl-delta-9-
THC essentially adopts Conformation I of the template. In this conformation,
the lone pairs of electrons of the phenol oxygen are directed toward Ring A.
However, the methoxy group cannot mimic Conformation II of the template in
which the lone pairs of electrons of the phenol oxygen are directed away from
Ring A. On the basis of these results, the inactivity of O-methyl-delta-9-THC
can be explained by the fact that the molecule cannot mimic Conformation II of
delta-9-THC. These results seem to indicate, then, that it is Conformation II
which is the more relevant conformation at the site of action.
In an early SAR study, Edery et al. (1971) postulated the need for a free phenol
for cannabinoid activity. Recently, Binder and Franke (1982) have proposed a
picture of delta-9-THC interacting with its hypothetical receptor. In this
picture, the phenolic hydrogen is shown to form a hydrogen bond with the
receptor. Such a hypothetical drawing implies the necessity of a phenolic
hydrogen for activity. It is possible to argue from this viewpoint that O-methyl-
delta-9-THC is inactive due to its lack of a phenolic hydrogen. Although the
demonstrated activity of some esterified THC would argue against the necessity
of a phenolic hydrogen for activity, there appears to be no definitive compound
yet synthesized which can answer this question. In the next stage of our
investigation, we hope to propose new cannabinoids which could be useful in
delineating an answer.
CONCLUSIONS
The finding that O-methyl-delta-9-THC cannot mimic Conformation II of delta-
9-THC in which the lone pairs of electrons of the phenol oxygen are directed
away from Ring A has led to a refinement of our template for cannabinoid
activity. This inability of O-methyl-delta-9-THC to mimic Conformation II may
cause the inactivity of the molecule. As a result of this finding, we have
tentatively refined our template for cannabinoid activity to include two aspects.
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FIGURE 10. Conformation of O-methyl-delta-9-THC (with propyl side chain)
as determined by MM2.
FIGURE 11. Conformation of O-methyl-delta-9-THC as determined by MM2:
here the perspective of Ring A is viewed in the direction parallel to the vector
from C2 to C1 O b .
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1. The first aspect is the orientation of the lone pairs of electrons of the
phenol oxygen such that these lone pairs point away from Ring A
(Conformation II) (these lone pairs generate directional reactivity
properties).
2. The second aspect is the orientation of Ring A such that the ring moves
out of the bottom face of the molecule (this conformation is likely to
allow for nondirectional hydrophobic interactions).
Further refinements of this template will be made in subsequent comparisons of
the template MRCs with those of other cannabinoids.
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